<SEC-DOCUMENT>0001157523-23-000904.txt : 20230524
<SEC-HEADER>0001157523-23-000904.hdr.sgml : 20230524
<ACCEPTANCE-DATETIME>20230523215242
ACCESSION NUMBER:		0001157523-23-000904
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230523
FILED AS OF DATE:		20230524
DATE AS OF CHANGE:		20230523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38885
		FILM NUMBER:		23950460

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a53405167.htm
<DESCRIPTION>ORGANIGRAM HOLDINGS INC. 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: business wire
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-weight: bold;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">FORM 6-K</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</div>
    <div style="text-align: center; font-weight: bold;"> UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div>&#160;</div>
    <div style="text-align: center;">For the month of May 2023</div>
    <div>&#160;</div>
    <div style="text-align: center;">Commission File Number: <font style="font-weight: bold; color: #000000;"><u>001-38885</u></font></div>
    <div>&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;"><u>ORGANIGRAM HOLDINGS INC.</u></div>
    <div style="text-align: center;">(Translation of registrant&#8217;s name into English)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">145 King Street West, Suite 1400</div>
    <div style="text-align: center; color: #000000; font-weight: bold;"><u>Toronto, Ontario, Canada M5H 1J8</u></div>
    <div style="text-align: center;"><font style="font-weight: bold;">&#160;</font>(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div>Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
    <div>&#160;</div>
    <div style="text-align: center;">Form 20-F&#160;[ &#160; ]<font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-weight: bold;">Form 40-F&#160;[ X ]</font></div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160;&#160;[&#160; ]</div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160; [&#160; ]</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">SUBMITTED HEREWITH</div>
    <div><br>
    </div>
    <div style="color: #000000; font-weight: bold;"><u>Exhibits</u></div>
    <div style="color: #000000; font-weight: bold;"><u> <br>
      </u></div>
    <u> </u>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z8813a8b6106f463c9282e2d662c90a72">

        <tr>
          <td style="width: 8%;"><a href="a53405167_ex991.htm">99.1</a><br>
          </td>
          <td style="width: 92%;"><a href="a53405167_ex991.htm">News Release dated May 23, 2023</a></td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
      thereunto duly authorized.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">ORGANIGRAM HOLDINGS INC.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="color: #000000;"><u>/s/ Derrick West&#160; &#160; &#160; &#160; &#160;&#160; </u></div>
    <div>Derrick West</div>
    <div>Chief Financial Officer</div>
    <div><br>
    </div>
    <div>Date: May 23, 2023</div>
    <div> <br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a53405167_ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: business wire
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">&#160;Exhibit 99.1</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div>
    <div class="bw-release">
      <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>Organigram to Enter German Market Supplying Sanity Group</b> </h1>
      <div class="bw-release-subhead">
        <ul style="list-style-type: disc;">
          <b>
            <li> <i>Organigram to supply the medical division of German cannabis company Sanity Group with high-quality medical flower for distribution in Germany.</i> </li>
            <li> <i>Germany is expected to legalize recreational cannabis and remains the largest addressable cannabis market in Europe as a result.</i> </li>
            <li> <i>Both Organigram and Sanity Group have received strategic investments from BAT</i> </li>
          </b>
        </ul>
      </div>
      <div class="bw-release-body">
        <div class="bw-release-table-js bw-release-story">
          <p>TORONTO--(BUSINESS WIRE)--May 23, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce today that it has entered into a supply agreement (&#8220;the
            Agreement&#8221;) for dried flower with the medical division of German cannabis company Sanity Group, a health and life sciences company based in Berlin, Germany, dedicated to the medical applications of cannabinoids. Through exports from its
            flagship state-of-the-art cultivation facility in Moncton, Organigram already services medical patients in Israel and Australia, and will now add Germany to its growing list of international markets. </p>
          <p> Under the terms of the Agreement, the Company will provide high-quality, indoor-grown dried flower product to Sanity Group and grant Sanity Group strain exclusivity on certain genetics. </p>
          <p> &#8220;With the German cannabis industry slowly moving toward a recreational adult-use model, we are excited to begin solidifying our relationships with reputable medical cannabis product developers and distributors like Sanity Group,&#8221; says Beena
            Goldenberg, Chief Executive Officer of Organigram. &#8220;We are committed to providing customers and medical patients in Australia, Israel, and now Germany, with high-quality cannabis, produced through industry-leading research, development and
            consumer-led insights.&#8221; </p>
          <p> &#8220;We look forward to bringing Organigram&#8217;s high-quality indoor-grown flower to our German medical patients,&#8221; said<b> </b>Finn Age H&#228;nsel, Managing Director &amp; Founder of Sanity Group. &#8220;Organigram consistently ranks as a leader in flower
            sales nationally in Canada and will be providing us with exclusivity on certain strains within the German market.&#8221; </p>
          <p> Activities under the Agreement are subject to compliance with all applicable laws, including receipt of all requisite approvals from Health Canada, the German Ministry of Health, and any other applicable regulatory authorities. </p>
          <p> <b>About Sanity Group</b> </p>
          <p> Berlin-based Sanity Group aims to improve people&#8217;s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on wellbeing and cosmetic products that utilize cannabinoids.
            Sanity Group, founded in Berlin in 2018 by Finn Age H&#228;nsel and Fabian Friede, includes Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (finished pharmaceuticals), Belfry Medical (medical products and digital
            applications), VAAY (wellbeing) and This Place (natural cosmetics). Near Frankfurt am Main, Sanity Group also operates a production and processing facility for cannabis extracts. More information can be found on sanitygroup.com/press. </p>
          <div> </div>
          <div style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt" id="DSPFPageBreakArea">
            <div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
              <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"> </div>
          </div>
          <p> <b>About Organigram Holdings Inc.</b> </p>
          <p> Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived products in Canada, and
            The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused edibles in Canada. </p>
          <p> Organigram is focused on producing high-quality, cannabis for patients and adult recreational consumers, as well as developing international business partnerships to extend the Company&#8217;s global footprint. Organigram has also developed and
            acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O&#8217; Buds, SHRED, SHRED&#8217;ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates facilities in Moncton, New
            Brunswick and Lac-Sup&#233;rieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). </p>
          <p> <b>Forward-Looking Information</b> </p>
          <p> This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as &#8220;plans&#8221;, &#8220;expects&#8221;, &#8220;estimates&#8221;, &#8220;intends&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221; or variations of
            such words and phrases or state that certain actions, events, or results &#8220;may&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;might&#8221; or &#8220;will&#8221; be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors
            that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in
            this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such
            forward-looking information include changes to market conditions, consumer preferences and regulatory climate, and factors and risks as disclosed in the Company&#8217;s most recent annual information form, management&#8217;s discussion and analysis and
            other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking
            statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not
            be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. This news release contains information concerning the cannabis industry and the markets in which the Company
            operates, including market position and market share, which is based on information from independent third-party sources. Although we believe these sources to be generally reliable, market and industry data is inherently imprecise, subject to
            interpretation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process, and other limitations and uncertainties inherent in any statistical
            survey or data collection process. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update
            or revise any forward-looking information, whether as a result of new information, future events or otherwise. </p>
        </div>
        <div class="bw-release-contact">
          <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
          <p> <b>For media enquiries:</b> </p>
          <p> Paolo De Luca <br>
            Chief Strategy Officer <br>
            paolo.deluca@organigram.ca </p>
          <p> <b>For investor enquiries:</b> </p>
          <p> Max Schwartz <br>
            Director of Investor Relations <br>
            investors@organigram.ca </p>
        </div>
      </div>
    </div>
    <font style="font-weight: bold;"> </font></div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div><font style="font-weight: bold;"> <br>
    </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
